Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Adenosine Triphosphate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY1 | P47900 | 8/20 | 0.79 |
| ▸ | P2RY11 | Q96G91 | 3/20 | 0.79 |
| ▸ | ENPP1 | P22413 | 2/20 | 0.76 |
| ▸ | BLM | P54132 | 2/20 | 0.75 |
| ▸ | TSHR | P16473 | 1/20 | 0.75 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.75 |
| ▸ | LMNA | P02545 | 1/20 | 0.75 |
| ▸ | P2RY2 | P41231 | 3/20 | 0.73 |
| ▸ | SRC | P12931 | 2/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.73 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.73 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.73 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.73 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.73 |
| ▸ | TRPM2 | O94759 | 2/20 | 0.73 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.73 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.73 |
| ▸ | LDHA | P00338 | 1/20 | 0.73 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Adenosine Triphosphate SCHEMBL29041389 | 1.00 | P2RY1 (0.79) | P2RY1P2RY11ENPP1BLMTSHR | |
| Adenosine Triphosphate SCHEMBL29480645 | 1.00 | P2RY1 (0.79) | P2RY1P2RY11ENPP1BLMTSHR | |
| Adenosine Triphosphate SCHEMBL28272946 | 0.99 | P2RY1 (0.77) | P2RY1P2RY11ENPP1BLMTSHR | |
| Adenosine Triphosphate SCHEMBL29576424 | 0.99 | P2RY1 (0.80) | P2RY1P2RY11ENPP1BLMTSHR | |
| Adenosine Triphosphate SCHEMBL193646 | 0.99 | P2RY1 (0.80) | P2RY1P2RY11ENPP1BLMTSHR | |
| Adenosine Triphosphate SCHEMBL29905572 | 0.99 | P2RY1 (0.80) | P2RY1P2RY11ENPP1BLMTSHR | |
| Adenosine Triphosphate SCHEMBL31149196 | 0.98 | P2RY1 (0.79) | P2RY1P2RY11ENPP1BLMTSHR | |
| Adenosine Triphosphate SCHEMBL924732 | 0.98 | P2RY1 (0.79) | P2RY1P2RY11ENPP1BLMTSHR | |
| Adenosine Triphosphate SCHEMBL3134374 | 0.98 | P2RY1 (0.79) | P2RY1P2RY11ENPP1BLMTSHR | |
| Lithium Ion SCHEMBL28406951 | 0.98 | P2RY1 (0.79) | P2RY1P2RY11ENPP1BLMTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 193 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120025982-A | Rectal cancer organoid culture kit and culture method thereof | 上海市浦东新区公利医院(第二军医大学附属公利医院) | 2025-05-23 | — | — | CN | claimed |
| CN-109991408-B | Antibody diluent composition, antibody diluent and preparation method thereof | 福州迈新生物技术开发有限公司 | 2022-07-01 | — | — | CN | claimed |
| CN-109991408-A | A kind of antibody diluent composition, antibody diluent and preparation method thereof | 福州迈新生物技术开发有限公司 | 2019-07-09 | — | — | CN | claimed |
| CN-101730470-A | Acaricidal active ingredient combinations | BAYER CROPSCIENCE AG | 2010-06-09 | — | — | CN | claimed |
| CN-1973825-A | Application of magnesium adenosine triphosphate as injection, injection and preparation method thereof | FAN KE (CN) | 2007-06-06 | — | — | CN | claimed |
| CN-1961865-A | Injection liquid of adenosine triphosphate magnesium and preparation method thereof | UNIV SHENYANG PHARMACEUTICAL (CN) | 2007-05-16 | — | — | CN | claimed |
| CN-1289094-C | Adenosine triphosphate salt composition and preparation method thereof | LIU XIAOQING (CN) | 2006-12-13 | — | — | CN | claimed |
| CN-1628691-A | Adenosine triphosphate salt composition and preparation method thereof | LIU XIAOQING (CN) | 2005-06-22 | — | — | CN | claimed |
| CN-1100266-C | Luciferase labelling method | SECR DEFENCE (GB) | 2003-01-29 | — | — | CN | claimed |
| EP-0778945-B1 | LUCIFERASE LABELLING METHOD | SECR DEFENCE (GB) | 2001-10-04 | — | — | EP | claimed |
| US-6255291-B1 | MIXTURE OF ALANINE, ADENOSINE COMPOUND, RIBOSE COMPOUND, ASCORBIC ACID AND NICOTINIC ACID | PEREGRINE PHARMACEUTICALS, INC. | 2001-07-03 | — | — | US | claimed |
| US-5837465-A | Luciferase labelling method | THE SECRETARY OF STATE FOR DEFENCE IN HER BRITANNIC MAJESTY'S GOVERNMENT OF THE UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND OF DEFENCE EVALUATION & RESEARCH AGENCY (GB) | 1998-11-17 | — | — | US | claimed |
| CN-1161746-A | Luciferase labelling method | SECR DEFENCE (GB) | 1997-10-08 | — | — | CN | claimed |
| EP-0778945-A2 | LUCIFERASE LABELLING METHOD | THE SECRETARY OF STATE FOR DEFENCE (GB) | 1997-06-18 | — | — | EP | claimed |
| WO-1996007100-A2 | LUCIFERASE LABELLING METHOD | THE SECRETARY OF STATE FOR DEFENCE (GB) | 1996-03-07 | — | — | WO | claimed |
| WO-2026102230-A2 | INCREASED NITROGEN FIXATION USING BACTERIA WITH MODIFIED ELECTRON TRANSPORT GENES | Bayer CropScience LLC (US) | 2026-05-15 | — | — | WO | disclosed |
| EP-4618744-A1 | INCREASED NITROGEN FIXATION USING BACTERIA WITH IMPROVED AMMONIA SECRETION | Bayer CropScience LP (US) | 2025-09-24 | — | — | EP | disclosed |
| EP-0507870-A1 | POLYHEMOGLOBIN STABILIZED BY PURINE DERIVATIVES AND GLUTATHIONE. | UNIV TEXAS TECH (US) | 1992-10-14 | — | — | EP | disclosed |
| WO-1992013875-A1 | IMPROVED BLOOD SUBSTITUTE | TEXAS TECH UNIVERSITY (US) | 1992-08-20 | — | — | WO | disclosed |
| WO-1991009615-A1 | POLYHEMOGLOBIN STABILIZED BY PURINE DERIVATIVES AND GLUTATHIONE | TEXAS TECH UNIVERSITY (US) | 1991-07-11 | — | — | WO | disclosed |